Key Points: In today’s Recommendations for Industry, we discuss the slight increase in cases around the U.S. Read more below. The FDA is warning consumers
Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly matrix and the “gentle swell” of COVID in the U.S. Read more below. CDC:
Key Points: In today’s Recommendations for Industry, we discuss low COVID levels across much of the U.S. with some regional levels of BA.2.12. Read more
Key Points: In today’s Recommendations for Industry, we discuss the current status of COVID and the conflicting news. Read more below. The CDC has extended
Key Points: In today’s Recommendations for Industry, we discuss decreasing COVID cases and advice to maintain the course. Read more below. A recent Duke University
Key Points: In today’s Recommendations for Industry, we discuss the “blip” in U.S. COVID cases, despite the fact that BA.2 has become the dominant variant.
Key Points: In today’s Recommendations for Industry, we discuss TAG’s interpretation of COVID trends being seen in TAG’s matrix and other news indicating a “nudge”
Key Points: In today’s Recommendations for Industry, we discuss the continued decline of COVID-19 cases and hospitalizations in the US and what Europe’s trends may
Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP
Key Points: In today’s Recommendations for Industry, we discuss the impact of the national COVID plans on workforce decision-making. Read more below. White House Releases
